Home
Rossari Biotech Ltd PE Ratio

Rossari Biotech Ltd
NSE: ROSSARI
PE
Key Highlights
- The P/E Ratio of Rossari Biotech Ltd is 25.9 as of 22 Feb 15:30 PM .
- The P/E Ratio of Rossari Biotech Ltd changed from 67.2 on March 2021 to 28.5 on March 2024 . This represents a CAGR of -19.30% over 4 years.
- The Latest Trading Price of Rossari Biotech Ltd is ₹ 637.35 as of 21 Feb 15:30 .
- The PE Ratio of Chemicals Industry has changed from 11.3 to 51.6 in 5 years. This represents a CAGR of 35.49%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Chemicals industry is 51.6. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Rossari Biotech Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Rossari Biotech Ltd
Company Fundamentals for Rossari Biotech Ltd

Rossari Biotech Ltd
NSE: ROSSARI
Share Price
Market Price of Rossari Biotech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 637.35 |
20 Feb 2025 | 637.9 |
19 Feb 2025 | 634.55 |
18 Feb 2025 | 629.4 |
17 Feb 2025 | 637.3 |
14 Feb 2025 | 638.15 |
13 Feb 2025 | 653 |
12 Feb 2025 | 674.9 |
11 Feb 2025 | 690.05 |
10 Feb 2025 | 714.75 |
SWOT Analysis Of Rossari Biotech Ltd
BlinkX Score for Rossari Biotech Ltd
Asset Value vs Market Value of Rossari Biotech Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Rossari Biotech Ltd | 3528 | 25.93 |
Pidilite Industries Ltd | 142121 | 70.9 |
SRF Ltd | 82293 | 71.8 |
Linde India Ltd | 52566 | 119.0 |
Gujarat Fluorochemicals Ltd | 40677 | 89.2 |
Godrej Industries Ltd | 38167 | 78.4 |
Company | |
---|---|
Rossari Biotech Ltd | 3528 |
Pidilite Industries Ltd | 142121 |
SRF Ltd | 82293 |
Linde India Ltd | 52566 |
Gujarat Fluorochemicals Ltd | 40677 |
Godrej Industries Ltd | 38167 |
PE Ratio of Rossari Biotech Ltd Explained
₹3528
Market cap
₹136
Earnings
25.9X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Chemicals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Rossari Biotech Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Rossari Biotech Ltd
Historical Revenue, EBITDA and Net Profit of Rossari Biotech Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Rossari Biotech Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Rossari Biotech Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Rossari Biotech Ltd
About Rossari Biotech Ltd
- Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry.
- It was further renamed to Rossari Biotech Limited and converted into a company in 2009.
- The Company has two state-of-the art facilities at Dahej, Gujarat and Silvassa, Dadra Nagar & Haveli and is mainly engaged in manufacturing, selling and distribution of specialty chemicals.
- The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. During the FY2020, 50,00,000 equity shares of face value of Rs 10 each was sub-divided into 2,50,00,000 Equity Shares of face value of Rs 2 each.
Rossari Biotech Ltd News Hub
Rossari Biotech to hold EGM
Rossari Biotech announced that an Extra Ordinary General Meeting (EGM) of the Company will be held o
Read more
21 Oct 24
Rossari Biotech announces board meeting date
Rossari Biotech will hold a meeting of the Board of Directors of the Company on 19 October 2024. Pow
Read more
14 Oct 24
Rossari Biotech consolidated net profit rises 7.22% in the September 2024 quarter
Net profit of Rossari Biotech rose 7.22% to Rs 35.33 crore in the quarter ended September 2024 as ag
Read more
19 Oct 24
Rossari Biotech allots 7,5000 equity shares under ESOP
Rossari Biotech has allotted 7,500 equity shares under ESOP on 21 January 2025. Consequently, the pa
Read more
21 Jan 25